Late-breaking abstract: Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
Paul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Robert S. Fishman, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David Lederer, Jonathan A. Leff, Steven D. Nathan, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, Talmadge E. King Jr
European Respiratory Journal 2014 44: P4501; DOI:
Paul W. Noble
1Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA,
Carlo Albera
2Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
Williamson Z. Bradford
3Research & Development, InterMune Inc., Brisbane, CA,
Ulrich Costabel
4Department of Pneumology, Ruhrlandklinik, Essen, Germany
Roland M. du Bois
5Respiratory Medicine, Imperial College, London, United Kingdom
Robert S. Fishman
3Research & Development, InterMune Inc., Brisbane, CA,
Ian Glaspole
6Interstitial Lung Disease, Alfred Hospital, Melbourne, Australia
Marilyn K. Glassberg
7Pulmonology, University of Miami Miller School of Medicine, Miami, FL,
Lisa Lancaster
8Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN,
David Lederer
9Department of Clinical Medicine, Columbia University Medical Center, New York, NY,
Jonathan A. Leff
3Research & Development, InterMune Inc., Brisbane, CA,
Steven D. Nathan
10Advanced Lung Disease & Transplant Program, Inova Fairfax Hospital, Falls Church, VA,
Carlos A. Pereira
11Department of Medicine, Paulista School of Medicine, São Paulo, Brazil
Jeffrey J. Swigris
12Department of Medicine, National Jewish Health, Denver, CO,
Dominique Valeyre
13Service de Pneumologie, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Bobginy, France
Talmadge E. King Jr
14Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA,
Vol 44 Issue Suppl 58
Table of Contents
Late-breaking abstract: Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
Paul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Robert S. Fishman, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David Lederer, Jonathan A. Leff, Steven D. Nathan, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, Talmadge E. King
European Respiratory Journal Sep 2014, 44 (Suppl 58) P4501;
Late-breaking abstract: Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
Paul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Robert S. Fishman, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David Lederer, Jonathan A. Leff, Steven D. Nathan, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, Talmadge E. King
European Respiratory Journal Sep 2014, 44 (Suppl 58) P4501;